PRODUCTS & SERVICES
Custom Oligonucleotides Services
The diagnostic kits vDetect and rTest are based on an improved and re-designed Charité Berlin protocol also recommended by the WHO.
We offer custom, high quality synthesis of aptamers, siRNA, miRNA, antagomirs, qPCR probes, oligonucleotide triphosphates etc.
MDX small RNA sequencing products are compatible with Illumina sequencing technology and designed for the simplest, the most economical, the most precise and automated small RNA library preparation, enabling a great elimination of sequencing errors and biases.
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining our proprietary visual and sequencing technologies into one diagnostic test.
MultiplexDX offers a wide range of bioinformatics services, including genome assembly, gene expression, metagenomics analyses and data visualization.
We are deligted to announce that our company, was selected as one of 75 companies, in a competition of 1,852 projects from all over Europe, to win a prestigious EIC Accelerator grant. Therefore, we became the first Slovak company in history to be awarded an EIC Accelerator by the European Innovation Council (EIC) in the full amount of 3 million EUR, of which MultiplexDX will provide a half million EUR from its own resources.
"The MultiplexDX 3'-adapters worked well in PAR-CLIP experiments to barcode and sequence different samples in the same lane. I would recommend these adapters to everyone that is going to perform the same kind of experiment."
"We have used - and continue using - custom made MultiplexDX 3'-adapters routinely for our small RNA library preparations - never fail."
"Mulitplex 3’-adapters have been very useful generating barcoded microRNA libraries from a large number of samples and extremely reliable in terms of their stability and compatibility with RNA ligation experiments. We have optimized protocols developed based on those adaptors and it is extremely likely to continue using them in future."